Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.49 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.49 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.49 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AY.49 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.49 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.49 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.49 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.49 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.49 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FZ.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FZ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FZ.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FZ.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FZ.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FZ.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
FY.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
FY.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
FY.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FY.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FY.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
FY.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
FY.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FY.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FY.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FY.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FY.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FY.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FY.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.497ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.497ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.497ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.497ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.497ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used